Since the start of the pandemic, we have supported a number of dermatology registries, starting with a COVID-19 registry. We are working with the American Academy of Dermatology (AAD) to support an Emerging Dermatophyte Registry and Mpox Registry. This is directed by Assistant Professor Esther Freeman from Harvard Medical School in Boston, USA.

Our hope is that the information you and others provide will help us understand the dermatologic manifestations of (1) drug-resistant dermatophytes and (2) COVID-19 or the mpox (monkeypox) virus, as well as skin reactions to the mpox vaccine.

The case report form should take about 5-7 minutes to complete. Patient identifiers such as name or date of birth will not be collected. All de-identified information will be kept strictly confidential and will only be shared with researchers compiling information. Data will be stored on a secure Redcap server at Massachusetts General Hospital. Information and updates will be shared via the Emerging Diseases American Academy of Dermatology website.

The success of this collaborative effort depends on active participation by our international health care community to obtain accurate and reliable information.

By clicking on this link, you acknowledge and agree that the American Academy of Dermatology is not responsible for the collection, maintenance, use, analysis, or disclosure of the data you submit to the registry, and that you are responsible for ensuring that you have the authority to submit the data you provide to the database and for de-identifying any Protected Health Information that you submit to the database in accordance with the applicable HIPAA regulations. Contact EmergingDiseases@aad.org with questions.